Literature DB >> 29796963

Validation of pharmacist-physician collaboration in psychiatry: 'the Eichberger-model'.

Martina Hahn1, Christoph Ritter2, Sibylle C Roll3.   

Abstract

Background Collaboration between physicians and pharmacists can increase medication safety. In the "Eichberger model" a clinical pharmacist is employed and working full time in a psychiatric hospital. Objective The aim of this study was to determine the expected type of expertise from a clinical pharmacist in psychiatry and the acceptance of the pharmacist's recommendations. Method All email requests to the clinical pharmacist from January 1st to April 30th 2015 were screened retrospectively and type of requester and content of request were extracted. Maintenance rate of drug therapy was analyzed by reviewing patient charts 2 weeks after medication prescription. Results A total of 147 requests were included. 85 (57.8%) requests were from attending physicians and 62 (42.2%) from residents. 82.1% of all physicians were contacting the clinical pharmacist during the study period. Most common reasons for requests were: appropriate drug selection (31.3%), drug interactions (25.2%), possible adverse drug events (17%) and switching drugs (12.2%). The acceptance rate by the physicians was 100%, with an implementation and maintenance rate of both 98.6%. Conclusion We found a high acceptance level of the pharmacist's recommendations. The pharmacist's skills were requested by the majority of physicians and included a in a large variety of specific questions. A pharmacist can play an important role to optimize patient care in collaboration with the physician in psychiatry.

Entities:  

Keywords:  Clinical pharmacist; Collaboration; Cooperation; Germany; Intervention; Psychiatry

Mesh:

Year:  2018        PMID: 29796963     DOI: 10.1007/s11096-018-0664-2

Source DB:  PubMed          Journal:  Int J Clin Pharm


  9 in total

1.  Acceptance and importance of clinical pharmacists' LIMM-based recommendations.

Authors:  Asa Bondesson; Lydia Holmdahl; Patrik Midlöv; Peter Höglund; Emmy Andersson; Tommy Eriksson
Journal:  Int J Clin Pharm       Date:  2012-01-18

2.  Clinical pharmacists' interventions in a German university hospital.

Authors:  Claudia Langebrake; Heike Hilgarth
Journal:  Pharm World Sci       Date:  2010-01-19

3.  The clinical pharmacist's contributions within the multidisciplinary patient care team of an intern nephrology ward.

Authors:  Gunar Stemer; Rosa Lemmens-Gruber
Journal:  Int J Clin Pharm       Date:  2011-08-10

Review 4.  Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature.

Authors:  James Gallagher; Suzanne McCarthy; Stephen Byrne
Journal:  Int J Clin Pharm       Date:  2014-09-14

Review 5.  Medication review in hospitalised patients to reduce morbidity and mortality.

Authors:  Mikkel Christensen; Andreas Lundh
Journal:  Cochrane Database Syst Rev       Date:  2016-02-20

6.  Pharmacist intervention acceptance for the reduction of potentially inappropriate drug prescribing in acute psychiatry.

Authors:  Sophia Hannou; Pierre Voirol; André Pannatier; Marie-Laure Weibel; Farshid Sadeghipour; Armin von Gunten; Jean-Frédéric Mall; Isabella De Giorgi Salamun
Journal:  Int J Clin Pharm       Date:  2017-09-13

Review 7.  Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis.

Authors:  Alemayehu B Mekonnen; Andrew J McLachlan; Jo-Anne E Brien
Journal:  BMJ Open       Date:  2016-02-23       Impact factor: 2.692

8.  Pharmacist-Led Medication Reviews to Identify and Collaboratively Resolve Drug-Related Problems in Psychiatry - A Controlled, Clinical Trial.

Authors:  Carolin Wolf; Anne Pauly; Andreas Mayr; Teja Grömer; Bernd Lenz; Johannes Kornhuber; Kristina Friedland
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

9.  Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany.

Authors:  L Cortejoso; R A Dietz; G Hofmann; M Gosch; A Sattler
Journal:  Clin Interv Aging       Date:  2016-09-26       Impact factor: 4.458

  9 in total
  1 in total

1.  Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial.

Authors:  Céline K Stäuble; Markus L Lampert; Samuel Allemann; Martin Hatzinger; Kurt E Hersberger; Henriette E Meyer Zu Schwabedissen; Christian Imboden; Thorsten Mikoteit
Journal:  Trials       Date:  2021-12-14       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.